Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats

BACKGROUND: Astragaloside IV (AS-IV) was reported to play a role in improving diabetic nephropathy (DN), however, the underlying mechanisms still remain unclear. The aim of the present study is to investigate whether AS-IV ameliorates DN via the regulation of endothelial nitric oxide synthase (eNOS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yuyan, Fan, Hongyu, Zhu, Bin, Zhou, Yilun, Liu, Qingshan, Li, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896771/
https://www.ncbi.nlm.nih.gov/pubmed/31805910
http://dx.doi.org/10.1186/s12906-019-2728-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896771/
https://www.ncbi.nlm.nih.gov/pubmed/31805910
http://dx.doi.org/10.1186/s12906-019-2728-9

Ejemplares similares